ARTICLE | Company News
Dendreon, GlaxoSmithKline deal
October 4, 2010 7:00 AM UTC
GlaxoSmithKline will produce the antigen used in Dendreon's Provenge sipuleucel-T treat prostate cancer. Dendreon has placed an order valued at about $8.3 million, to be delivered beginning August 20...